New program aims to boost medication adherence in breast cancer survivors

NCT ID NCT05496829

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program to help people with early-stage breast cancer take their hormone therapy and heart medications as prescribed. Participants receive a pharmacist review, training on using a patient portal, and a reminder app. The goal is to see if this support improves medication adherence at 24 and 52 weeks, which could lower the risk of cancer recurrence and heart problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Multicomponent Adherence Intervention (behavioral: pharmacist session, patient portal training, reminder app)
What this could lead to
If successful, this program could help breast cancer patients stick to their medications, potentially reducing cancer recurrence and heart disease risk.
What could go wrong
This is a behavioral intervention, not a new drug, so its impact is limited to improving adherence. The trial is relatively small (350 participants) and relies on self-reporting, which may not be fully accurate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Columbia University Medical Center

    RECRUITING

    New York, New York, 10032, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.